top of page


11 April 2024

Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer

07 November 2023

Nuevocor presents pre-clinical data at ESGCT and AHA meetings

21 December 2022

Nuevocor to Present at Biotech Showcase during JPM week and at Keystone Symposium on Heart Development and Disease

28 October 2022

Nuevocor to Present Pre-clinical Data on its Gene Therapy Candidate for LMNA Dilated Cardiomyopathy at American Heart Association Scientific Sessions 2022

18 April 2022

Nuevocor Founders to Present at the American Society of Gene and Cell Therapy (ASGCT) 2022 Meeting

18 June 2021

Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies

bottom of page